Idag presenterar GPX Medicals verkställande direktör Hanna Sjöström och CTO PhD Sara Bergsten på BioStock live.

Följ sändningen på https://www.biostock.se/2020/09/direktsant-biostock-live-med-curasight-toleranzia-lifeclean-och-gpx-medical/

Sändningen börjar kl. 13.00 och GPX Medical presenterar cirka kl. 14.20.

GPX Medical avser noteras på Nasdaq First North Growth Market Stockholm den 2 oktober 2020. Teckningsperioden har nu startat och löper fram till och med den 21 september 2020. Teckna enkelt genom våra partners Nordnet, Avanza och Eminova.

Today, Tuesday 8 September, BioStock live takes place. You can watch and listen to presentation and interview with CEO Hanna Sjöström and CTO PhD Sara Bergsten.

GPX Medical is underway to be listed at Nasdaq First North Growth Market Stockholm on October 2nd 2020. Subscription period is currently underway. Subscription can be made at eminova.se and mordent.se

About GPX Medical

GPX Medical AB is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hanna.sjostrom@gpxmedical.se

Contact

GPX Medical AB
Tellusgatan 13
224 57 Lund
Sweden
info@gpxmedical.se

Organization number: 559069-9012